Skip to main content
. 2023 Oct 11;23(1):1381–1386. doi: 10.1007/s40200-023-01320-3

Table 1.

Data items collected by the registry

Demographics Disease history Paraclinical results Surgery Follow-up visit Medical management risk and stage calculation Complications
Identification History related to thyroid cancer Sonography of thyroid Surgical pathology characteristics (tumor type, histological grade, lymph node involvement, and invasion) Levothyroxine therapy dose Resurgery TNM stage surgical
Residence past medical/ surgical history including genetic disorders related to thyroid cancer, hospital admission history, and radiation therapy Thyroid scan with technetium Laboratory test results Imaging (whole body scan, CT scan, bone scan, PET scan, MRI, and BMD) Dynamic risk stratification TKI complications
Nationality Drug history FNA result Medical therapy (radioiodine dose, TKI, EBR, RFA, and alcohol injection) Radioactive iodine
Education, job, and insurance Family history (thyroid cancer, neck or thyroid surgery, radioiodine ablation, head and neck radiotherapy, and others) Molecular study Levothyroxine
Family style Physical examination (general characteristics, thyroid exam, and others) Gene translocations External beam radiation
Others like physical activity and nutrition Other complications

FNA, fine needle aspiration; PET, positron emission tomography; MRI, magnetic resonance imaging; BMD, bone mineral density; TKI, tyrosine kinase inhibitor; EBR, external beam radiation; RFA, radiofrequency ablation; TNM, tumor, node, metastasis